| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1999;68:1034-1038
© 1999 The Society of Thoracic Surgeons
a First Department of Surgery, Kanazawa University School of Medicine, Kanazawa, Japan
Address reprint requests to Dr Ohta, First Department of Surgery, Kanazawa University School of Medicine, Takara-machi 13-1, Kanazawa 920-8641, Japan
e-mail: yohta{at}med.kanazawa-u.ac.jp
Abstract
Background. Tumor angiogenesis appears to relate to recurrence after an operation as a route for distant metastasis. We assessed the association of vascular endothelial growth factor (VEGF) expression and intratumoral microvessel density (MD) with recurrence in primary lung cancer.
Methods. Samples were randomly obtained from 104 stage I lung cancer patients who underwent curative operations (43 recurrent, 61 nonrecurrent patients). Microvessels were highlighted by staining endothelial cells for factor VIII and VEGF antigen was detected using a polyclonal antibody.
Results. VEGF antigen was detected in large amounts in both recurrent (100%) and nonrecurrent tumors (73.8%). The percentages of patients with the strongest VEGF stain (more than 50% of staining area in tumor cells) were 46.5% in tumors with recurrence and 11.5% in tumors without recurrence. The mean MD in recurrent and nonrecurrent tumors were 18.2 ± 10.5 and 8.5 ± 5.0, respectively, resulting in a significantly greater value in tumors with recurrence (p < 0.0001). Although there were no significant differences in mean MD according to pathological types, in adenocarcinoma and adenosquamous carcinoma, the mean value in the recurrent group was significantly greater than that in the nonrecurrent one.
Conclusions. An evaluation of VEGF expression and MD in tumors may contribute to the estimation of the risk of recurrence of non-small cell lung cancer in early stages.
This article has been cited by other articles:
|
|
 |
|
  Y. Zou, M. Zhang, Q. Wang, D. Shang, L. Wang, and G. Yu Quantitative Investigation of Solitary Pulmonary Nodules: Dynamic Contrast-Enhanced MRI and Histopathologic Analysis Am. J. Roentgenol., July 1, 2008; 191(1): 252 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sardari Nia, C. Colpaert, P. Vermeulen, J. Weyler, F. Pezzella, P. Van Schil, and E. Van Marck Different Growth Patterns of Non-Small Cell Lung Cancer Represent Distinct Biologic Subtypes Ann. Thorac. Surg., February 1, 2008; 85(2): 395 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W Hilbe, S Dirnhofer, F Oberwasserlechner, T Schmid, E Gunsilius, G Hilbe, E Woll, and C M Kahler CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer J. Clin. Pathol., September 1, 2004; 57(9): 965 - 969. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Campione, T. Ligabue, L. Luzzi, C. Ghiribelli, P. Paladini, L. Voltolini, M. Di Bisceglie, M. Lonzi, and G. Gotti Impact of Size, Histology, and Gender on Stage IA Non-Small Cell Lung Cancer Asian Cardiovasc Thorac Ann, June 1, 2004; 12(2): 149 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sayar, A. Turna, O. Solak, A. Kilicgun, N. Urer, and A. Gurses Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Ann. Thorac. Surg., February 1, 2004; 77(2): 421 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Spiro and J. C. Porter Lung Cancer--Where Are We Today?: Current Advances in Staging and Nonsurgical Treatment Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1166 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ohta, N. Ohta, M. Tamura, J. Wu, Y. Tsunezuka, M. Oda, and G. Watanabe Vascular Endothelial Growth Factor Expression in Airways of Patients With Lung Cancer* : A Possible Diagnostic Tool of Responsive Angiogenic Status on the Host Side Chest, May 1, 2002; 121(5): 1624 - 1627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.S. Brock and S.M. Lee Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer Eur. Respir. J., March 1, 2002; 19(3): 557 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ohta, M. Oda, J. Wu, Y. Tsunezuka, M. Hiroshi, A. Nonomura, and G. Watanabe Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis J. Thorac. Cardiovasc. Surg., November 1, 2001; 122(5): 900 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kara, Y. Ohta, Y. Tanaka, M. Oda, and Y. Watanabe Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer Ann. Thorac. Surg., March 1, 2001; 71(3): 944 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ohta, H. Nozawa, Y. Tanaka, M. Oda, and Y. Watanabe INCREASED VASCULAR ENDOTHELIAL GROWTH FACTOR AND VASCULAR ENDOTHELIAL GROWTH FACTOR-C AND DECREASED NM23 EXPRESSION ASSOCIATED WITH MICRODISSEMINATION IN THE LYMPH NODES IN STAGE I NON-SMALL CELL LUNG CANCER J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 804 - 813. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
